How to launch a skincare brand comes down to sequence: manufacturing route before brand name, minimum order quantity before product roadmap, safety assessment before the copy is written, packaging costed before it is chosen, one channel proven before a second is added. Get the order wrong and each stage can look fine alone while the launch quietly fails.
I spent almost twenty years working on some of the biggest beauty brands in the industry — L'Oréal Group, Coty, YSL Beauty, Giorgio Armani, Lancôme and Rimmel. What that record gives me is the commercial view of a launch rather than a formulator's: what it costs, what order the decisions have to be taken in, and which of them a corporate structure quietly absorbs on your behalf. An indie founder carries all of those herself, which is the whole reason sequence matters more to her than it ever did to a brand inside a large corporate.
How to launch a skincare brand: the manufacturing route comes before the brand
Before there is a name, a bottle or a brand voice, there is a formulation and a route to make it at volume: an in-house lab you build and own, or a contract manufacturer whose formulation you licence and whose production line you queue for. Each carries a different cost profile, a different speed to first batch, and a different answer to who owns the intellectual property in the formula itself. That decision, own it or rent it, is a bigger and more separate question than a launch article can resolve properly, and it deserves its own careful comparison rather than a paragraph here. What matters for the sequence is smaller and harder to argue with: whichever route you pick decides your cost base, your lead time and your flexibility before a single other launch decision gets made, so it has to be settled first, not discovered halfway through building a brand identity around a formulation that was never confirmed.
What a minimum order quantity actually commits you to
A contract manufacturer's minimum order quantity is not a production detail, it is a capital decision dressed as one. Whatever number a manufacturer quotes you, that is stock you are paying for before you know whether anyone wants it, sitting in a warehouse rather than in your bank account, for as long as it takes to sell through. Founders tend to discover this mid-negotiation rather than plan around it, and by then a supplier's number, not the founder's own roadmap, is quietly deciding how many SKUs launch, how much of each, and how long the business can wait before the next production run has to be funded. That interaction between the minimum order and everything downstream of it, cash, range width, timing, is worth working through properly before you sign anything, and it is exactly the kind of decision a founder should stress-test with someone who is not the manufacturer quoting the number.
The safety assessment is a timeline item, not paperwork at the end
This is a process fact, not a claims one, and it belongs here because of when it happens, not what it lets you say. Before a cosmetic product can be made available to consumers in Great Britain, its safety has to be checked by a qualified safety assessor, the Responsible Person has to keep a Product Information File on it, and the product has to be notified to the Office for Product Safety and Standards before it goes on sale (GOV.UK, "Making cosmetic products available to consumers in Great Britain": https://www.gov.uk/guidance/making-cosmetic-products-available-to-consumers-in-great-britain). Those are the duties the guidance sets out, and none of them is optional. What the guidance does not tell you is how long any of it takes in your particular case, so ask your safety assessor and your Responsible Person for their own lead times early and build the plan around their answer rather than around your launch date. My own recommendation, offered as judgement rather than as anything the guidance says: treat this as a critical-path item between formulation and launch, not as paperwork to be slotted in after the packaging has gone to print. An assessor needs a finished, stable formulation to work from rather than a working draft, which means the step cannot start until the formulation stops moving. The founders who get caught out are not skipping it. They are scheduling it last, after the marketing plan is already built. What a product can actually say about itself, and where a cosmetic claim tips into a medicinal one, is a separate and detailed question that this piece is deliberately not answering; get the safety file finished and the substantiation in hand before copy gets written, and settle the claims question properly rather than by instinct.
Packaging and the unit economics nobody stress-tests early enough
The packaging brief usually gets written before the unit economics are tested against it, and that is the wrong order for the same reason the manufacturing decision has to come first. A jar, a pump, a printed carton and an insert card each turn up as separate cost lines long before there is a shipped unit to weigh them against, and a beautiful format chosen at the mood-board stage can quietly break the margin at the price point you actually need to charge. My rule, and it is a rule of thumb rather than a formula anyone else should copy exactly: cost the fully landed unit, packaging included, against the real shelf or checkout price before a format gets signed off, not after. A pump dispenser costs the same whether it goes on a unit priced at a premium or a unit priced to compete, which means it is a different decision in each case and survivable in only one of them. No amount of liking the way it looks in the hand changes that maths.
Choosing the first channel, and how the earlier decisions already narrowed it
By the time you reach channel, the manufacturing route and the minimum order have already ruled some options out. A wholesale buyer working in case packs wants a volume commitment that only makes sense once you know your true unit cost and your minimum order cadence; a small first run built to prove a formulation before you scale it is often a poor fit for a retail buyer's opening order, and a far better fit for a direct channel you control while you are still learning. This is not the general case for pick one channel and prove it there, which applies to any founder-led launch. It is the specific, skincare version of that same discipline: your channel choice is already constrained by the stock and cost decisions two steps back, and pretending otherwise is how a founder ends up promising a retailer volume the manufacturing plan cannot deliver on the agreed timeline.
What the first ninety days need to prove, for a skincare product specifically
A skincare product is consumed and finished, unlike a lot of what gets launched under the same generic playbook. Whatever your formulation's realistic usage life turns out to be, the honest test of the first ninety days is not how many people buy once, it is whether the same customer comes back once the jar or the bottle actually runs out. A launch can look strong on first purchase and still be built on a product nobody finishes, or finishes and does not miss, and that difference does not show up until the natural repurchase window arrives. Watching for it earlier than that, chasing a second sale before the first one is even used up, tells you nothing except that a discount code works, which was never in question.
Where you can, get an outside read on the sequence before the manufacturer's quote and the packaging brief have already set the direction for you. That is a conversation worth having early rather than after the first production run is booked, and it sits closer to a sounding board than a full engagement, which is what Strategic Counsel is actually for. Get in touch while the decisions are still open, not once they have already been made by default.
Frequently asked questions
Do I need to own a formulation lab to launch a skincare brand? No, and I would not advise it as a starting point. A contract manufacturer's existing or lightly adapted formulation is the ordinary route into the category, and owning a lab is a later-stage decision with its own cost and control trade-offs rather than a launch requirement.
What is a Product Information File, and when do I need one? It is the document a Responsible Person is legally required to keep on every cosmetic product sold in Great Britain, alongside the safety assessment and the notification to the Office for Product Safety and Standards, and it has to exist before the product is made available to consumers, not after a query arrives.
Does the minimum order quantity change depending on the channel I sell through? Not directly, but the two interact closely. A manufacturer's minimum order is fixed regardless of where you sell, while a wholesale buyer's own opening order requirement sits on top of it, so the combination can commit more capital and stock than either number suggests on its own.
Should I launch with one product or a small range? One, and I would argue that fairly hard. A single, well-proven product gives you a clean read on repurchase and on whether the manufacturing and channel decisions were right, before you multiply any mistakes in them across a range.
Author: Kirsty Newman is Founder of The Boutique Consultancy. She spent almost two decades at some of the largest corporate powerhouses in beauty and luxury, including YSL Beauty, Giorgio Armani Beauty, Lancôme and Rimmel (L'Oréal Group and Coty). She went on to work with a number of startups as they scaled, before striking out on her own. Across this time, she has run seven-figure P&Ls and teams of 16, with direct engagement in venture capital funding and expansion.